Company: INVUP
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001193
Chunk: 1217

Company: Investview, Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 1
Chunk 1217
---
 policy.

[2]This amount is
equal to the $1,780,000
purchase price less $572,386
of customer deposits collected by Renu Labs,
Inc. prior to acquisition.

Renu
Laboratories LLC recorded revenue of $110,671 and net loss of $291,227 since the October 11, 2024 acquisition date, which were included
in our consolidated statement of operations for the year ended December 31, 2024.

The
table below represents the pro forma revenue and net income (loss) for the years ended December 31, 2023 and 2024, assuming the acquisition
had occurred on January 1, 2023, pursuant to ASC Subtopic 805-10-50. This pro forma information does not purport to represent what the
actual results of our operations would have been had the acquisition occurred on this date nor does it purport to predict the results
of operations for future periods.

 SCHEDULE
OF PROFORMA REVENUE AND NET INCOME LOSS

    December
    31, 2024  
    December
    31, 2023 
  
    Revenue 
    $1,327,940  
    $1,534,369 
  
    Net (loss) 
    $(325,257) 
    $(43,736)
  
    Loss per common share 
    $(0.00) 
    $(0.00)

    F-25

INVESTVIEW,
INC.

NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER
31, 2024 AND 2023

NOTE
13 – INCOME TAXES

Deferred
taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating
loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences
are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a
valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets
will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of
enactment. The Company used an effective tax rate of 21% when calculating the deferred tax assets and liabilities and income tax provision
below.

The
Company’s income (loss) before income taxes were broken